Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Myomo, Inc. (MYO)

0.5092   0.009 (1.84%) 02-03 14:30
Open: 0.5 Pre. Close: 0.5
High: 0.5096 Low: 0.482
Volume: 316,819 Market Cap: 4(M)

Technical analysis

as of: 2023-02-03 2:18:45 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.67     One year: 0.79
Support: Support1: 0.45    Support2: 0.37
Resistance: Resistance1: 0.57    Resistance2: 0.67
Pivot: 0.47
Moving Average: MA(5): 0.49     MA(20): 0.47
MA(100): 0.97     MA(250): 2.24
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 76.4     %D(3): 69
RSI: RSI(14): 51
52-week: High: 8.07  Low: 0.36
Average Vol(K): 3-Month: 1,220 (K)  10-Days: 542 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ MYO ] has closed below upper band by 15.8%. Bollinger Bands are 72% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 20 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.53 - 0.53 0.53 - 0.53
Low: 0.47 - 0.48 0.48 - 0.48
Close: 0.5 - 0.5 0.5 - 0.5

Company Description

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Headline News

Wed, 01 Feb 2023
7 Top Short-Squeeze Candidates to Watch in February - InvestorsObserver

Wed, 01 Feb 2023
Myanmar: Two Years After The Tatmadaw’s Coup - Forbes

Tue, 31 Jan 2023
Win Myo Thu – Asia Times - Asia Times

Tue, 31 Jan 2023
Treasury Sanctions Officials and Military-Affiliated Cronies in Burma ... - Treasury

Mon, 30 Jan 2023
Myomo (MYO) Appoints Yitzchak Jacobovitz to its Board -

Thu, 26 Jan 2023
Large New Zealand Study Confirms Safety Profile of Pfizer ... -

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 7 (M)
Shares Float 6 (M)
% Held by Insiders 3.5 (%)
% Held by Institutions 37.2 (%)
Shares Short 73 (K)
Shares Short P.Month 55 (K)

Stock Financials

EPS -1.76
EPS Est Next Qtl -0.34
EPS Est This Year -5.54
EPS Est Next Year -0.89
Book Value (p.s.) 2.25
Profit Margin (%) -68.6
Operating Margin (%) -68
Return on Assets (ttm) -35.3
Return on Equity (ttm) -71.5
Qtrly Rev. Growth 127.5
Gross Profit (p.s.) 0.72
Sales Per Share 1.98
EBITDA (p.s.) -1.34
Qtrly Earnings Growth 0
Operating Cash Flow -9 (M)
Levered Free Cash Flow -6 (M)

Stock Valuations

PE Ratio -0.29
PEG Ratio 8.9
Price to Book value 0.22
Price to Sales 0.25
Price to Cash Flow -0.4

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.